Korneyev, I.A.,
Alexeeva, T.A.,
Al-Shukri, S.H.,
Bernikov, A.N.,
Erkovich, A.A.,
Kamalov, A.A.,
Kogan, M.I.,
Pavlov, V.N.,
Zhuravlev, V.N.,
Pushkar, D.Y. (2016) in 530 (48.
9%) men, consisting of mild and mild to moderate, moderate and severe ED in 375 (34.6%), 78 (7
Objectives: Pathological heart rate turbulence (HRT) after ventricular
premature beats 20-2000/24
h, secondly the multifactor (
9 factors) mathematical model and computer program “Kardiorisk” of mortality risk
Shaymardanova, E.Kh.,
Nurgalieva, A.Kh.,
Khidiyatova, I.M.,
Gabbasova, L.V.,
Kuramshina, O.A.,
Kryukova, A.Ya.,
Sagitov, R.B.,
Munasipov, F.R.,
Khusnutdinova, E.Kh. (2016) MMP1 (rs1799750,
rs494379), MMP2 (rs2285052), MMP3 (rs3025058), MMP
9 (rs3918242, rs17576), and MMP12
-inflammatory and antiarrhythmic [7], analgesic [8], hepatoprotective [
9], antihyperglycemic
[10], and antioxidant [11] activity
disease (CHD) patients (63.
9 ˘ 1.6 years) with stable angina pectoris NYHA
II-III and a control group